Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVE5530 in primary hypercholesterolemia
NCT00718965Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Jul 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Canosimibe in hypercholesterolemia, sponsored by Sanofi. Started Jul 2008; status: terminated.
02
Drugs
Canosimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00718965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718965.